|

Ivonescimab Combined With TROP2 ADC Clinical Trials

1 actively recruiting trial

Also known as: AK112 Combined With TROP2 ADC

Pipeline

Phase 2: 1

Top Sponsors

  • Fudan University1

Indications

  • Triple Negative Breast Cancer (TNBC)1
  • Brain Metastases1
  • Breast Cancer1
  • Cancer1

Other1 trial

BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.